Načítá se...
A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic Dyslipidemia
BACKGROUND: Diabetes mellitus and concomitant dyslipidemia, being referred to as ‘diabetic dyslipidemia’, are the foremost detrimental factors documented to play a pivotal role in cardiovascular illness. Diabetic dyslipidemia is associated with insulin resistance, high plasma triglyceride levels, lo...
Uloženo v:
| Vydáno v: | Curr Mol Pharmacol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bentham Science Publishers
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6875865/ https://ncbi.nlm.nih.gov/pubmed/30636619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874467212666190111165015 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|